2020. Evaluation of the bioequivalence of two formulations containing the combination of 400 mg of acetaminophen (paracetamol), 4 mg of phenylephrine and 4 mg of chlorpheniramine in capsules: open-label, three-way crossover study, partially replicated in health. Brazilian Journal of Pharmaceutical Sciences. 56, (Dec. 2020), e17836 . DOI:https://doi.org/10.1590/s2175-97902020000217836.